General Anesthesia Drug Market Key Players, Production and Growth Rate Forecast by 2017-2022

Global general anesthesia drug market is segmented on the basis of type, routes of administration, molecule, application and geography. General anesthesia drugs are used to induce a sedative state in patients who are to go through a surgical procedure. Further, general anasthesia drugs can be segmented into two sub-segments based on the route of administration, general anesthesia drugs administered through the intravenous route is categorized as an intravenous anesthetic and general anesthesia drugs administered through inhalation is categorized as an inhalation anesthetic.

It is a must to maintain the sedative stage in the patient during a surgical procedure, usually for this stage, inhalation anesthesia are administered to the patients; while for the induction stage, intravenous general anaesthesia is preferred. Increasing number of surgeries, development of new sedative & anesthetic drugs, and reduction in the cost of newly invented drugs and decrease in the recovery time after surgery are some of the reasons driving the growth of the market.

Get Details of General Anesthesia Drug Market Report at :

Risk of side effects of anesthesia drugs, lack of skilled anesthetists to administer the drugs and risk of adverse reactions of anesthesia drugs are some of the major constraints hindering the market growth. Growth of the general anesthesia drugs market is mainly driven by rising incidences of cardiovascular diseases, chronic respiratory diseases, craniomaxillofacial surgeries and accidents. However, lack of a single effective drug for all type of surgeries, side effects and complications during the surgical procedure, lack of skilled anesthesiologists and certified registered nurse anesthesiologists, inadequate insurance coverage, coupled with high prices of these drugs are restraining market growth. In addition, side effects such as nausea, vomiting, allergy, sleep apnea and complications during surgical procedures are anticipated to drive the demand for improvement in the quality of drugs.

On the basis of type, the general anesthesia drug market is segmented into spinal anesthesia, general anesthesia, interscalene block, IV regional anesthesia, local anesthesia, saddle block anesthesia, peripheral nerve block and so on. These drugs are usually used to assist surgery. These drugs are used to produce loss of consciousness before and during surgery. However, for obstetrics (labor and delivery) or certain minor procedures, an anesthetic may be given in small amounts to relieve anxiety or pain without causing unconsciousness. Some of the anesthetics may be used for certain procedures in a medical doctor’s or dentist’s office. On the basis of routes of administration, the general anesthesia drug market is segmented into inhalation, intravenous and injection. On the basis of molecule, the general anesthesia drug market is segmented into propofol, benzodiazepine (midazolam and diazepam), ketamine (esketamine hydrochloride or S-(+) – ketamine hydrochloride), methohexital sodium, and so on.

Get Sample Copy of General Anesthesia Drug Market at: 

On the basis of geography, the general anesthesia drug industry is segmented into Asia Pacific, North America, Latin America, Europe and Middle East & Africa. On the basis of application, the general anesthesia drug industry is segmented into hospital use and clinic use. North America dominated the market share of the overall general anaesthesia drugs market in 2015.The key players in general anesthesia drug industry include AstraZeneca Plc., Fresenius-Kabi, AbbVie Laboratories, Baxter Healthcare, B.Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals, Mylan N.V., Eisai Co. Ltd.,Fresenius Se & Co. KgaA, Abbott, Hospira Inc., Novartis, Roche, Nhwa, Hengrui, Boehringer Ingelheim, Par Pharmaceutical Companies Inc. and Lunan.

This report studies General Anesthesia Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
• AstraZeneca
• Fresenius-Kabi
• BbVie Laboratories
• Baxter Healthcare
• Braun
• Maruishi
• Piramal Healthcare
• Hikma Pharmaceuticals
• Mylan
• Nhwa
• Lunan
• Hengrui

See More Market Research Report Related to This Category at:

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of General Anesthesia Drugs in these regions, from 2011 to 2022 (forecast), like
• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
• Inhalation Anesthestic
• Intravenous Anesthestic

Split by applications, this report focuses on sales, market share and growth rate of General Anesthesia Drugs in each application, can be divided into
• Hospital Use
• Clinic Use

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:
Ryan Manuel
Research Support Specialist, USA

Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Visit Our Blog:

Leave a Reply